Seeing Is Believing
Currently out of the existing stock ratings of Yaron Werber, 61 are a BUY (70.93%), 24 are a HOLD (27.91%), 1 are a SELL (1.16%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 60.03% that have a potential upside of 26.02% achieved within 273 days. Previously, Yaron Werber worked at COWEN.
Yaron Werber’s has documented 161 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 25-Jun-2024.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
303
$-28.29 (-8.54%)
310
15 days ago
12/13 (92.31%)
$-22.09 (-6.80%)
700
Buy
340
$8.71 (2.63%)
300
29 days ago
8/9 (88.89%)
$26.31 (8.39%)
512
Buy
332
$0.71 (0.21%)
328
1 months 12 days ago
10/10 (100%)
$33.38 (11.18%)
72
Hold
235
$-96.29 (-29.07%)
223
2 months 17 days ago
16/20 (80%)
$-75.65 (-24.35%)
415
Hold
300
$-31.29 (-9.44%)
230
2 months 23 days ago
17/19 (89.47%)
$-9.09 (-2.94%)
246
Which stock is Yaron Werber is most bullish on?
Which stock is Yaron Werber is most reserved on?
What Year was the first public recommendation made by Yaron Werber?